PropertyValue
?:abstract
  • [Image: see text] The outbreak of COVID-19 by the end of 2019 has posed serious health threats to humanity and jeopardized the global economy. However, no effective drugs are available to treat COVID-19 currently and there is a great demand to fight against it. Here, we combined computational screening and an efficient cellular pseudotyped virus system, confirming that clinical HDAC inhibitors can efficiently prevent SARS-CoV-2 and potentially be used to fight against COVID-19.
is ?:annotates of
?:creator
?:doi
  • 10.1021/acsptsci.0c00163
?:doi
?:externalLink
?:journal
  • ACS_Pharmacol_Transl_Sci
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/fb1aba2c54c3e68f4e797d97f8295709e42d8d0e.json; document_parses/pdf_json/8b6733b2ab075ebd963557d97391b6cffac5ca18.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7671100.xml.json
?:pmcid
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:sha_id
?:source
  • PMC
?:title
  • Clinical HDAC Inhibitors Are Effective Drugs to Prevent the Entry of SARS-CoV2
?:type
?:year
  • 2020-11-10

Metadata

Anon_0  
expand all